TG Therapeutics (TGTX) and Neuraxpharm Announce Ex-US Commercialization Agreement for BRIUMVI

Go back to TG Therapeutics (TGTX) and Neuraxpharm Announce Ex-US Commercialization Agreement for BRIUMVI
TG THERAP (NASDAQ: TGTX) Delayed: 55.80 -0.18 (0.32%)
Previous Close $55.98    52 Week High $14.87 
Open $55.34    52 Week Low $4.90 
Day High $55.93    P/E N/A 
Day Low $54.09    EPS $-0.67 
Volume 730,674